ATLASEditas Medicine (EDIT) earnings date: Nov 9, 2026
Editas Medicine (EDIT) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$0.21.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EDIT
| Last price | $2.58 (-3.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.3% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Editas Medicine stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Editas Medicine reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Editas Medicine. You can switch it off at any time.
Alert me before EDIT reportsFree to start. Creating an account takes under a minute.
Notify me when Editas Medicine reports
Track EDIT free Add Editas Medicine to a free ATLAS watchlist and see its next report date in one place.
EDIT earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.21 |
| Last report | Aug 5, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +30.6% |
| Average move around a report | ±12.6% (last 5) |
| Sector | Healthcare · Biotechnology |
Editas Medicine earnings history: last 5 reports
Editas Medicine last reported on Aug 5, 2026: EPS of -$0.15 against an estimate of -$0.28 (+46.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.28 | -$0.15 | +46.4% | Beat | +4.7% |
| Jun 17, 2026 | $3.12 | $3.16 | +1.3% | In line | +14.0% |
| May 5, 2026 | -$0.24 | -$0.26 | -8.3% | Miss | +5.8% |
| Apr 21, 2026 | $1.52 | $2.16 | +42.1% | Beat | -6.7% |
| Mar 9, 2026 | -$0.21 | -$0.06 | +71.4% | Beat | +32.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EDIT
See the fair value, the probability range and the earnings history of Editas Medicine on its ATLAS page.
Editas Medicine (EDIT) stock analysisPlans from €3.99 a month.
Editas Medicine earnings: frequently asked questions
When does Editas Medicine (EDIT) report earnings?
Editas Medicine is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EDIT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.21 per share (USD). Estimates can change before the report.
How often does EDIT beat earnings estimates?
Of its last 5 reports with a recorded result, Editas Medicine beat the EPS estimate 3 times; the average surprise was +30.6%. Past results do not predict the next one.
How much does EDIT move around earnings?
Over its last 5 reports the stock moved an average of 12.6% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Editas Medicine beat earnings estimates last quarter?
Editas Medicine last reported on Aug 5, 2026: EPS of -$0.15 against an estimate of -$0.28 (+46.4% surprise), a beat.
How much does EDIT usually move in a day?
On a normal trading day the ATLAS model puts EDIT’s one-day range at about ±5.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer